Replies to post #325878 on Bioelectronics Corp (BIEL)

[ddls]

Even after all their lies about new deals last year? Maybe it's the No Pain deal that's keeping you put here. That makes pump #56 that will amount to zero revenue for BIEL. ActiPatch was a non contender in the FDA Opioid Challenge 2017-18.